Current Trends in Mucosal Melanomas: An Overview
Cancers · 21.02.2023 · 15 (5) · 1356
DOI: 10.3390/cancers15051356 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 21.02.2023. Verfasst von Davide Adriano Santeufemia und 11 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Unit, Alghero General Hospital, 07041 Alghero, Italy. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health—Ricerca Corrente.
Abstract (Originalsprache)
Primary mucosal melanomas (MMs) are uncommon tumors originating from melanocytes located in the mucous membranes at various anatomic sites within the body. MM significantly differs from cutaneous melanoma (CM) regarding epidemiology, genetic profile, clinical presentation, and response to therapies. Despite these differences, that have important implications for both disease diagnosis and prognosis, MMs are usually treated in the same way as CM but exhibit a lower response rate to immunotherapy leading to a poorer survival rate. Furthermore, a high inter-patient variability can be observed in relation to therapeutic response. Recently, novel “omics” techniques have evidenced that MM lesions have different genomic, molecular, and metabolic landscapes as compared with CM lesions, thus explaining the heterogeneity of the response. Such specific molecular aspects might be useful to identify new biomarkers aimed at improving the diagnosis and selection of MM patients who could benefit from immunotherapy or targeted therapy. In this review, we have focused on relevant molecular and clinical advancements for the different MM subtypes in order to describe the updated knowledge relating to main diagnostic, clinical, and therapeutic implications as well as to provide hints on likely future directions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oncology Unit, Alghero General Hospital, 07041 Alghero, Italy.
- Immuno-Oncology & Targeted Cancer Biotherapies, Unit of Cancer Genetics, University of SassariIRGB-CNR, 07100 Sassari, Italy.
- Preventive Medical Oncology, CRO Aviano, National Cancer Institute, IRCCS, 33081 Aviano, Italy.
- Institute of Genetic and Biomedical Research (IRGB), National Research Council (CNR), 07100 Sassari, Italy.
- Department of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy.
- Department of Clinical and Experimental Medicine, Gynecologic and Obstetric Clinic, University of Sassari, 07100 Sassari, Italy.
ORCID-Profile: Davide Adriano Santeufemia, Giuseppe Palmieri, Gianmaria Miolo, Maria Grazia Doro, Panagiotis Paliogiannis, Giampiero Capobianco, Antonio Cossu, Giuseppe Corona
Förderung
- Italian Ministry of Health—Ricerca Corrente
Zitieren
APA
Santeufemia, D. A., Palmieri, G., Miolo, G., Colombino, M., Doro, M. G., Frogheri, L., Paliogiannis, P., Capobianco, G., Madonia, M., Cossu, A., Lo Re, G., & Corona, G. (2023). Current Trends in Mucosal Melanomas: An Overview. Cancers, 15(5), 1356. https://doi.org/10.3390/cancers15051356
Vancouver
Santeufemia DA, Palmieri G, Miolo G, Colombino M, Doro MG, Frogheri L, et al. Current Trends in Mucosal Melanomas: An Overview. Cancers. 2023;15(5):1356. doi:10.3390/cancers15051356
BibTeX
@article{Santeufemia2023,
author = {Santeufemia, Davide Adriano and Palmieri, Giuseppe and Miolo, Gianmaria and Colombino, Maria and Doro, Maria Grazia and Frogheri, Laura and Paliogiannis, Panagiotis and Capobianco, Giampiero and Madonia, Massimo and Cossu, Antonio and Lo Re, Giovanni and Corona, Giuseppe},
title = {Current Trends in Mucosal Melanomas: An Overview},
journal = {Cancers},
year = {2023},
volume = {15},
number = {5},
pages = {1356},
doi = {10.3390/cancers15051356}
}
EUVIMED